1. Home
  2. AMWL vs UNCY Comparison

AMWL vs UNCY Comparison

Compare AMWL & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Well Corporation

AMWL

American Well Corporation

HOLD

Current Price

$4.62

Market Cap

111.4M

Sector

Technology

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$6.54

Market Cap

126.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMWL
UNCY
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.4M
126.4M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
AMWL
UNCY
Price
$4.62
$6.54
Analyst Decision
Hold
Strong Buy
Analyst Count
7
4
Target Price
$7.58
$44.50
AVG Volume (30 Days)
88.7K
435.2K
Earning Date
02-11-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$265,023,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.33
N/A
52 Week Low
$3.71
$3.71
52 Week High
$12.95
$11.00

Technical Indicators

Market Signals
Indicator
AMWL
UNCY
Relative Strength Index (RSI) 44.97 58.72
Support Level $4.64 $6.01
Resistance Level $5.29 $6.66
Average True Range (ATR) 0.31 0.47
MACD -0.05 0.05
Stochastic Oscillator 5.00 74.03

Price Performance

Historical Comparison
AMWL
UNCY

About AMWL American Well Corporation

American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: